| Literature DB >> 32359704 |
J Cañueto1, A Tejera-Vaquerizo2, P Redondo3, R Botella-Estrada4, S Puig5, O Sanmartin6.
Abstract
Cutaneous squamous cell carcinoma (cSCC) is the second most common cancer in humans and its incidence is both underestimated and on the rise. cSCC is referred to in the literature as high-risk cSCC, locally advanced cSCC, metastatic cSCC, advanced cSCC, and aggressive cSCC. These terms can give rise to confusion and are not always well defined. In this review, we aim to clarify the concepts underlying these terms with a view to standardizing the description of this tumor, something we believe is necessary in light of the new drugs that have been approved or are in development for cSCC.Entities:
Keywords: Carcinoma epidermoide cutáneo; Carcinoma epidermoide cutáneo de alto riesgo; Carcinoma escamoso cutáneo; Cutaneous squamous cell carcinoma; Estadificación; High-risk cutaneous squamous cell carcinoma; Staging
Mesh：
Year: 2020 PMID： 32359704 DOI： 10.1016/j.ad.2019.06.005
Source DB: PubMed Journal: Actas Dermosifiliogr (Engl Ed) ISSN： 2173-5778